Appeal No. 2006-1066 Page 2 Application No. 09/810,109 any form of behavior that indicates an altered or reduced ability to make decisions resulting, at least in part, from the use of alcohol or opiates. . . . This term also includes the psychic craving for alcohol or an opiate that may or may not be accompanied by a physiological dependency. . . . Forms of “dependency” include habituation, that is, an emotional or psychological dependence on alcohol or an opiate to obtain relief from tension and emotional discomfort; tolerance, that is, the progressive need for increasing doses to achieve and sustain a desired effect; addiction, that is, physical or physiological dependence which is beyond voluntary control; and use of alcohol or an opiate to prevent withdrawal symptoms. Page 4, line 19, to page 5, line 6. To treat alcohol dependency, as well as the other conditions, the specification describes “administering a therapeutically-effective amount of a cytidine-containing, cytosine-containing, creatine-containing, uridine-containing, adenosine-containing, or adenosine-elevating compound to a mammal.” Page 3, lines 18-20. The specification defines “therapeutically-effective amount” as an amount of the compound “sufficient to produce a healing, curative, prophylactic, stabilizing, or ameliorative effect in the treatment of” the various conditions, including alcohol dependency. Page 8, lines 13-19. Discussion 1. Claims Claims 1 and 5-17 are pending and on appeal. Claim 1 is independent. Claims 5-17 each depend, directly or indirectly, from claim 1. Claims 5-7, 9-11, and 14-17 stand or fall together with claim 1. Appeal Brief, page 4. Claims 8, 12 and 13 were separately argued. Thus, we will focus on claims 1, 8, 12 and 13, which are representative and read as follows: 1. A method of treating alcohol dependency, comprising administering to a mammal a therapeutically-effective amount of a compound selected from the group consisting of a cytidine-containing compound, a cytosine-containing compound, a uridine-containingPage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 NextLast modified: November 3, 2007